Logo yposkesi
waves image

Yposkesi to host roundtable on challenges in gene therapy manufacturing at the Cell and Gene Meeting on the Mesa, October 2-4

As more gene therapies advance to clinical trials, participants will discuss which are the best strategies for manufacturing to scale.

Corbeil-Essonnes, France, September 24, 2019 – Yposkesi, a leading Contract Development and Manufacturing Organization (CDMO) for preferred access and reserved capacity for cGMP grade viral vector production, today announces it will host a roundtable luncheon on ‘Addressing today’s gene therapy manufacturing challenges’ at the Cell and Gene Meeting on the Mesa, organized by the Alliance for Regenerative Medicine.

 

Read the press release